Biohaven Ltd., a New Haven-based bioscience firm, its chief executive officer and its chief financial officer are being sued ...

Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now. Earlier on June 10, Bexorg Inc., which is a techbio company focused on central nervous system/CNS disorders, announced ...

Biohaven’s valuation has dropped from $3.9B to $1.42B, but no revenue and high cash burn still limit its appeal. Read why ...

P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf ...

Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd.

--Biohaven Ltd., a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common ...

Shares of Biohaven Ltd. BHVN climbed 13% premarket on Monday after the biotech company said its treatment for a rare neurological disorder slowed the progress of the condition in a clinical trial.

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to ...

Biohaven Pharmaceutical said on Monday its experimental drug for patients with spinocerebellar ataxia, a genetic disease that affects the nervous system, failed to meet the main goal of a late ...

--Biohaven Pharmaceutical Holding Company Ltd. today announced a Patient Savings Program for NURTEC™ ODT that is now available for eligible commercially insured patients. The U.S. Food and Drug ...

Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now. Earlier on June 10, Bexorg Inc., which is a techbio company focused on central nervous system/CNS disorders ...